null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

Net debt ~$1.6B, leverage ratio ~6x EBITDA; 20% rate rise adds ~$32M annual interest expense on floating-rate tranches

~60% of debt estimated floating-rate; 20% increase in base rate compresses free cash flow by ~$25-35M annually, meaningful given thin FCF margins

Low intensity; China and India supply >60% of global API inputs, creating concentration risk.

1) Taiwan/Southeast Asia medical device component manufacturing; 2) Single-source OEM medical equipment suppliers (GE, Philips, Siemens)

Predominantly US-domestic (~95%+ revenue); minimal sovereign currency devaluation exposure; not meaningfully internationally diversified

~95% US revenue; negligible FX exposure; currency devaluation risk effectively non-material for current operating model

Low intensity; commodities: Active Pharmaceutical Ingredients, Rare Earth Elements, Natural Gas (energy), Plastics/Resins, Ethanol, Packaging Materials; geopolitical: China and India supply >60% of global API inputs, creating concentration risk.

High dependency on OEM manufacturers (GE HealthCare, Philips, Siemens Healthineers) for equipment supply; substitution difficult within 12-month window

Asset-based medical equipment rental/service; cloud dependency moderate; 30-day termination disruptive but not existential given physical asset model

Managed services/outsourced equipment lifecycle management; cloud loss would impair logistics/tracking software but core ops physically resilient

Moderate-high API coupling to hospital EHR/CMMS systems; switching costs elevated by integration depth but no single dominant API dependency

Revenue model is equipment rental and services; clearly fails Howey Test — no investment contract, no expectation of profit from others' efforts; risk negligible

Very High

Handles patient-adjacent equipment data; HIPAA primary compliance burden; GDPR exposure minimal given US-only footprint; CCPA applicable but limited PHI scope

Moderate; post-THL Partners leveraged buyout and consolidation of medical equipment services, FTC scrutiny possible but no active proceedings identified

Very High burden; regimes: FDA, CMS, HHS, HIPAA, EMA, OIG; Drug pricing legislation and approval delays directly compress revenue visibility.

~70-75% recurring (multi-year hospital service contracts, managed programs); ~25-30% transactional (per-event rentals, repair services)

Long-term hospital outsourcing contracts plus transactional equipment rental; recurring contract base provides revenue visibility 12-24 months forward

Cost-plus with contractual escalators; pricing stress risk from hospital budget pressure and GPO negotiations limiting unilateral price increases

Moderate; mission-critical service reduces churn but hospital GPO leverage and reimbursement pressure constrain meaningful price increases above CPI

Gross margin ~35-42%; asset-intensive model with depreciation and field technician labor compressing margins below pure SaaS benchmarks

Low free-rider risk; physical asset custody model prevents leakage; however contract renewal risk real given hospital consolidation reducing buyer count

Revenue growth is headcount-linear; field biomedical technicians scale with service volume; limited automation leverage in physical equipment servicing

Near-linear; each incremental service contract requires additional field technicians and equipment inventory; marginal cost does not decline significantly at scale

null

At 10x scale, CAC likely rises as remaining hospital systems harder to onboard; GPO relationships key leverage point; unit economics compress modestly

Weak network effects; scale provides procurement leverage with OEMs but no user-to-user network dynamic; durability low as pure scale advantage

AI displacement risk low-moderate; biomedical technician work partially automatable via predictive maintenance AI but physical repair cannot be fully displaced

Tier 1 recession resistant; hospitals maintain medical equipment regardless of economic cycle; elective procedure volume dips but critical care equipment demand stable

Acute care hospitals and health systems (estimated 60-70% of revenue); top 10 customers likely represent 30-40% of total revenue

Specialty clinics, surgery centers, and federal/government healthcare facilities; growing segment but smaller than acute hospital base

["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "19-0000 Life, Physical, and Social Science Occupations", "21-0000 Community and Social Service Occupations", "23-0000 Legal Occupations", "29-0000 Healthcare Practitioners and Technical Occupations", "31-0000 Healthcare Support Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "51-0000 Production Occupations"]

0.32 (HIL — ~32% of characteristic roles agent-automatable)

Capital allocated primarily to equipment fleet expansion and maintenance; limited legacy-to-future reallocation signal; capex remains operationally sustaining not transformative

1757898

AGTI